Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study.

Saved in:
Bibliographic Details
Title: Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study.
Authors: Xiao, Le1 (AUTHOR), Zhao, Qian1 (AUTHOR), Li, An-ning1 (AUTHOR), Sun, Jushui2 (AUTHOR), Wu, Bin3 (AUTHOR), Wang, Lina4 (AUTHOR), Zhang, Honggeng5 (AUTHOR), Zhang, Ruiling6 (AUTHOR), Li, Keqing7 (AUTHOR), Xu, Xiaojin8 (AUTHOR), Liu, Tiebang9 (AUTHOR), Zhang, Wenshun9 (AUTHOR), Xie, Shiping10 (AUTHOR), Xu, Xiufeng11 (AUTHOR), Tan, Yunlong12 (AUTHOR), Zhang, Kerang13 (AUTHOR), Zhang, Hongyan14 (AUTHOR), Guan, Nianhong15 (AUTHOR), Xian, Mingji16 (AUTHOR), Uki, Motomichi17 (AUTHOR)
Source: Psychopharmacology. Jan2022, Vol. 239 Issue 1, p243-251.
Database: SPORTDiscus with Full Text
Full text is not displayed to guests.
Description
ISSN:00333158
DOI:10.1007/s00213-021-06044-x